Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.
Lee LS, Sim AYL, Ong CW, Yang X, Ng CCY, Liu W, Rajasegaran V, Lim AMS, Aslim EJ, Ngo NT, Khor LY, Kanesvaran R, Allen JCJ, Tay KJ, Yuen JSP, Chong TW, Ho SSH, Teh BT, Chua MLK. Lee LS, et al. Among authors: ong cw. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):741-748. doi: 10.1038/s41391-022-00496-8. Epub 2022 Jan 28. Prostate Cancer Prostatic Dis. 2022. PMID: 35091711 Free PMC article. Clinical Trial.
Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.
Lee LS, Sim AYL, Ong CW, Yang X, Ng CCY, Liu W, Rajasegaran V, Lim AMS, Aslim EJ, Ngo NT, Khor LY, Kanesvaran R, Allen JCJ, Tay KJ, Yuen JSP, Chong TW, Ho SSH, Teh BT, Chua MLK. Lee LS, et al. Among authors: ong cw. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):803. doi: 10.1038/s41391-022-00522-9. Prostate Cancer Prostatic Dis. 2022. PMID: 35288663 Free PMC article. No abstract available.
Risk of tuberculosis disease in patients receiving TNF-α antagonist therapy: A meta-analysis of randomized controlled trials.
Khelghati F, Rahmanian M, Eghbal E, Seghatoleslami ZS, Goudarzi M, Keramatinia A, Ong CW, Goletti D, D'Ambrosio L, Centis R, Nasiri MJ, Migliori GB. Khelghati F, et al. Among authors: ong cw. New Microbes New Infect. 2024 Nov 16;62:101533. doi: 10.1016/j.nmni.2024.101533. eCollection 2024 Dec. New Microbes New Infect. 2024. PMID: 39639969 Free PMC article. Review.
Expert views on screening for tuberculosis infection in patients commencing treatment with a biologic agent.
Sultana A, Migliori GB, D'Ambrosio L, García-García JM, Silva DR, Rendon LA, Codecasa LR, Blanc FX, Tiberi S, Ong CWM, Heffernan C, Sotgiu G, Centis R, Dobler CC; Global Tuberculosis Network. Sultana A, et al. Among authors: ong cwm. J Bras Pneumol. 2024 Sep 27;50(4):e20240082. doi: 10.36416/1806-3756/e20240082. eCollection 2024. J Bras Pneumol. 2024. PMID: 39356910 Free PMC article.
Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease.
Ang MLT, Chan SM, Cheng LT, Cheong HY, Chew KL, Chlebicki PM, Hsu LY, Kaw GJL, Kee ACL, Ng MCW, Ong RTH, Ong CWM, Quah JL, Selvamani DB, Sng LH, Tan JBX, Tan CH, Tay JY, Teo LLS, Thoon KC, Yan GZ, Chen JI, Hud BMH, Khoo BBJ, Lee DYX, Ng BXY, Park JY, Tan BYT, Yang Q. Ang MLT, et al. Among authors: ong cwm. Ann Acad Med Singap. 2024 Mar 27;53(3):170-186. doi: 10.47102/annals-acadmedsg.2023391. Ann Acad Med Singap. 2024. PMID: 38920244 Free article. Review.
209 results